12th Pharmacovigilance 2017
In-Person Event
Feb 22 - 23, 2017
London, England, GBSpeakers
OVERVIEW
12th Pharmacovigilance is organized by Virtue Insight and would be held during Feb 22 - 23, 2017 at Pestana Chelsea Bridge Hotel, London, England, United Kingdom.
12th Annual Pharmacovigilance 2017 will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. The entire program will cover the detection, analysis and prevention of adverse drug reactions. It will be studied with the help of case studies and industry experiences. This conference will help the drug safety representatives from the pharmaceutical industry and academic and quality research organisations who wish to understand how to avoid common deficiencies in inspections by learning from the experiences of others; to gain a greater understanding of new and existing pharmacovigilance requirements, and to improve their organisations' compliance with pharmacovigilance requirements. Also it can help you control your product's lifecycle, your patient's trust, and your revenue. Hence, this conference will provide an important platform for pharmacovigilance stakeholders to discuss and share best practices in expediting pharmacovigilance development. It gives me great pleasure in welcoming all of you to the Virtue Insight’s 12th Pharmacovigilance 2017.
KEY THEMES:-
• Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading?
• Updates towards of legislation, policies, systems, technology, communication strategies and best practice in PV
• The effect of Brexit on Pharmacovigilance
• Specifics of the GVP module V on Risk Management Systems
• Emerging signal detection data gathering successful tools to highlight emerging risks
• Analysing the Challenges and Opportunities to optimize the overall PV ecosystem for maximum benefit
• Revised GVP guidance on signal management – how to implement?
• Updates to PSUR, PBRERs, DSUR, PASS
• Building cost effective and scalable systems
• Case studies from various countries on the PV frameworks around the world
• Business development and models in clinical trials
• Good Clinical Practices and Good Pharmacovigilance practices
• IT and new technologies for improvement of PV and clinical research
• Strategies to improve clinical trials and PV
• Maintaining proper balance in relationships: Sponsor – Site – CRO & Patients
• Patient centric approach to help improve patient safety
• Outsourcing activities - How to set it right?
• PV Audit & inspections - preparation, implementation and lessons to be learnt
• Discover approaches for collecting, integrating and analyzing all of the safety data generated from preclinical models
• Investigating the current regulations and guidelines on USA and EU PV
• The developing regulatory framework in advanced and developing markets
• Accelerating new medicine introduction in developing world & overcoming challenges
• Be part of a major networking opportunity
12th Annual Pharmacovigilance 2017 will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. The entire program will cover the detection, analysis and prevention of adverse drug reactions. It will be studied with the help of case studies and industry experiences. This conference will help the drug safety representatives from the pharmaceutical industry and academic and quality research organisations who wish to understand how to avoid common deficiencies in inspections by learning from the experiences of others; to gain a greater understanding of new and existing pharmacovigilance requirements, and to improve their organisations' compliance with pharmacovigilance requirements. Also it can help you control your product's lifecycle, your patient's trust, and your revenue. Hence, this conference will provide an important platform for pharmacovigilance stakeholders to discuss and share best practices in expediting pharmacovigilance development. It gives me great pleasure in welcoming all of you to the Virtue Insight’s 12th Pharmacovigilance 2017.
KEY THEMES:-
• Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading?
• Updates towards of legislation, policies, systems, technology, communication strategies and best practice in PV
• The effect of Brexit on Pharmacovigilance
• Specifics of the GVP module V on Risk Management Systems
• Emerging signal detection data gathering successful tools to highlight emerging risks
• Analysing the Challenges and Opportunities to optimize the overall PV ecosystem for maximum benefit
• Revised GVP guidance on signal management – how to implement?
• Updates to PSUR, PBRERs, DSUR, PASS
• Building cost effective and scalable systems
• Case studies from various countries on the PV frameworks around the world
• Business development and models in clinical trials
• Good Clinical Practices and Good Pharmacovigilance practices
• IT and new technologies for improvement of PV and clinical research
• Strategies to improve clinical trials and PV
• Maintaining proper balance in relationships: Sponsor – Site – CRO & Patients
• Patient centric approach to help improve patient safety
• Outsourcing activities - How to set it right?
• PV Audit & inspections - preparation, implementation and lessons to be learnt
• Discover approaches for collecting, integrating and analyzing all of the safety data generated from preclinical models
• Investigating the current regulations and guidelines on USA and EU PV
• The developing regulatory framework in advanced and developing markets
• Accelerating new medicine introduction in developing world & overcoming challenges
• Be part of a major networking opportunity
KEY DATES
22 Feb, 2017
Event Start Date
23 Feb, 2017
Event End Date
SPECIALITIES
Pharmacy and MedicineSUGGESTED HOTELS
CONFERENCE VENUE
Pestana Chelsea Bridge Hotel & SpaRELATED CONFERENCES & LIVE WEBINARS
Quick Links